CDDO Methyl Ester
SIGMA/SMB00376 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 218600-53-4
Empirical Formula (Hill Notation): C32H43NO4
Molecular Weight: 505.69
MDL Number: MFCD11983137
Linear Formula: C32H43NO4
Product Type: Chemical
| application(s) | metabolomics vitamins, nutraceuticals, and natural products |
| assay | ≥98% (HPLC) |
| form | powder |
| InChI | 1S/C32H43NO4/c1-27(2)11-1 |
| InChI key | WPTTVJLTNAWYAO-KPOXMGGZSA |
| Quality Level | 200 ![]() |
| SMILES string | CC1(C)CC[C@]2(C(OC)=O)CC[ |
| storage temp. | −20°C |
| Application: | CDDO Methyl Ester has been used to test its effect on hepatocyte membrane transporters (HMTs) regulation and mitigation of cholestasis in hepatic ischemia-reperfusion injury (IRI). It has also been used activator of NF E2 Related Factor 2 (NRF2) to study its role in preventing cell death in melanoma cells. |
| Biochem/physiol Actions: | CDDO-Me inhibits inflammatory mediators including interleukin-6 (IL-6), IL-10, and IL-12. It enhances apoptosis induced by TNF and chemotherapeutic agents. CDDO-Me exhibits anti-proliferative activity in osteosarcoma cells and enhances the effectiveness of chemotherapeutic agents by inducing an intrinsic mitochondrial-dependent apoptotic pathway. It can be used as an adjuvant treatment for advanced and fatal form of prostate cancer. |
| General description: | CDDO-Me is a synthetic triterpenoid compound with anti-inflammatory, anti-tumor and cytoprotective properties. It is derived from the natural product oleanic acid. |
| Packaging: | 10 mg in glass bottle |
| Packaging: | 100 mg in poly bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352205 |

